September 9, 2025
Addition of accomplished Healthcare investor with significant business growth and operations experience reflects BCI Private Equity’s continued global team expansion
VICTORIA, NEW YORK, LONDON – September 9, 2025 – British Columbia Investment Management Corporation (“BCI”), one of Canada’s largest institutional investors, is pleased to announce the appointment of Nikhil Hanmantgad as Managing Director for BCI Private Equity. In this role, Mr. Hanmantgad will be responsible for identifying and executing new investments in BCI Private Equity’s global healthcare vertical as well as leading value creation opportunities across the healthcare portfolio. Mr. Hanmantgad will report to Jon Salon, Senior Managing Director, who joined BCI in July 2024 to lead BCI Private Equity’s healthcare coverage.
“We are thrilled to welcome Nikhil to BCI’s Private Equity team. His appointment underscores our ongoing commitment to strengthening our healthcare focus and advancing our targeted investment strategy in a sector experiencing strong momentum,” said Jim Pittman, Executive Vice President & Global Head, Private Equity at BCI.
“Our team is distinguished by the deep healthcare investing experience of our senior professionals, including those who are former CEOs and founders, bringing invaluable insights to our partnerships with leading management teams,” added Mr. Salon. “Nikhil’s combination of investment acumen and hands-on operating experience makes him a great addition as we continue to expand our capabilities in this critical sector.”
Mr. Hanmantgad brings two decades of healthcare investing and operating experience to BCI. Throughout his career, he has led the execution of over $2.5 billion in invested capital across growth equity and buy-outs of healthcare businesses. Most recently, Mr. Hanmantgad served as Private Equity Senior Principal at Mubadala, a $330 billion UAE sovereign wealth fund, where he helped lead the U.S. healthcare team.
“Having founded and led healthcare businesses, I’ve seen firsthand the complexities and opportunities that management teams navigate,” said Mr. Hanmantgad. “I’m excited to join BCI Private Equity’s healthcare sector team, where the emphasis on operational excellence and value creation is deeply embedded.”
Prior to Mubadala, Mr. Hanmantgad was a Principal and member of the Investment Committee at Health Catalyst Capital, a lower-middle-market healthcare private equity fund. Mr. Hanmantgad also brings significant operating experience, having served as CEO of MedTools, a healthcare IT business that drove improved access and utility of information on medical devices for surgeons and hospital procurement departments. He has also held board roles and portfolio company responsibilities for Norstella, Zelis, PCI Pharma, Datavant, Clearsense, Simplifeye, and Clareto. Mr. Hanmantgad earned an MBA from Columbia University Graduate School of Business and a Bachelor of Science in Finance from New York University Stern School of Business.
Mr. Hanmantgad joins BCI Private Equity as the program continues to expand globally, following the recent opening of its European office in London and expansion of its European team to support growing investment activity across European markets. Today, BCI’s Private Equity team has more than 70 professionals across offices in Victoria, British Columbia, New York City, and London, investing across geographies and market cycles with a focus on proactive liquidity management.
